Find a Psychiatrist | Psychiatrist Directory | Psychiatry Resources Online
Medicine News » Psychiatry News » Pierre Fabre, Forest Laboratories report positive Phase III MDD study data - Pharmaceutical Business Review
 

Pierre Fabre, Forest Laboratories report positive Phase III MDD study data - Pharmaceutical Business Review

Posted on April 27th, 2012, 9:50 am


Pierre Fabre, Forest Laboratories report positive Phase III MDD study data
Pharmaceutical Business Review
Pierre Fabre pharmaceutical division president Frederic Duchesne said, "These results confirm the relevance of our strategic choice to make neuropsychiatry a major focus of Pierre Fabre R&D." Levomilnacipran (1S, 2R-milnacipran), an enantiomer of ...

Recommend this news article 0